Inicio>>Signaling Pathways>> Chromatin/Epigenetics>> Histone Acetyltransferases>>KAT8 Inhibitor 19

KAT8 Inhibitor 19 (Synonyms: Lysine Acetyltransferase 8 Inhibitor 19)

Catalog No.GC91622

KAT8 inhibitor 19 is an inhibitor of lysine acetyltransferase 8 (KAT8; IC50 = 12.1 µM).

Products are for research use only. Not for human use. We do not sell to patients.

KAT8 Inhibitor 19 Chemical Structure

Cas No.: 28532-21-0

Tamaño Precio Disponibilidad Cantidad
1 mg
35,00 $
Disponible
5 mg
140,00 $
Disponible
10 mg
245,00 $
Disponible
25 mg
525,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

KAT8 inhibitor 19 is an inhibitor of lysine acetyltransferase 8 (KAT8; IC50 = 12.1 µM).[1] It is selective for KAT8 over KAT2A, KAT2B, KAT3B, KAT6A, and KAT7 at 200 µM. KAT8 (50 µM) reduces histone 4 lysine 16 acetylation (H4K16Ac) in HT-29 colorectal carcinoma cells. It reduces the viability of HCT116, H1299, A549, and U937 cancer cells (IC50s = 39.4, 52.1, 41, and 30.1 µM, respectively).

References:
[1].Fiorentino, F., Sementilli, S., Menna, M., et al.First-in-class selective inhibitors of the lysine acetyltransferase KAT8J. Med. Chem.66(10)6591-6616(2023).

Reseñas

Review for KAT8 Inhibitor 19

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for KAT8 Inhibitor 19

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.